Hardin Capital Partners LLC Makes New $626,000 Investment in Danaher Corporation $DHR

Hardin Capital Partners LLC bought a new position in shares of Danaher Corporation (NYSE:DHR) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 2,825 shares of the conglomerate’s stock, valued at approximately $626,000.

Other hedge funds also recently modified their holdings of the company. Pacifica Partners Inc. bought a new position in Danaher in the 3rd quarter valued at about $239,000. Stableford Capital II LLC lifted its holdings in shares of Danaher by 292.4% during the 3rd quarter. Stableford Capital II LLC now owns 18,766 shares of the conglomerate’s stock worth $4,158,000 after acquiring an additional 13,984 shares during the period. Mn Services Vermogensbeheer B.V. boosted its position in shares of Danaher by 1.2% during the 3rd quarter. Mn Services Vermogensbeheer B.V. now owns 188,136 shares of the conglomerate’s stock worth $41,682,000 after acquiring an additional 2,200 shares in the last quarter. Diversified Management Inc. acquired a new stake in shares of Danaher during the 3rd quarter worth approximately $1,583,000. Finally, Acropolis Investment Management LLC increased its stake in Danaher by 537.8% in the third quarter. Acropolis Investment Management LLC now owns 4,388 shares of the conglomerate’s stock valued at $972,000 after acquiring an additional 3,700 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 0.5%

Shares of NYSE:DHR opened at $217.33 on Friday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a market capitalization of $152.78 billion, a PE ratio of 38.60, a price-to-earnings-growth ratio of 2.72 and a beta of 0.76. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The company has a fifty day moving average of $210.88 and a 200-day moving average of $194.44.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same quarter last year, the business posted $0.77 EPS. On average, equities analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is presently 28.42%.

Analyst Ratings Changes

Several equities research analysts have weighed in on DHR shares. The Goldman Sachs Group upped their target price on Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research note on Monday, September 21st. Royal Bank Of Canada boosted their price target on Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a report on Monday. Barclays raised their price objective on Danaher from $230.00 to $255.00 and gave the company an “overweight” rating in a research note on Wednesday. Wells Fargo & Company decreased their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. Finally, UBS Group assumed coverage on Danaher in a research note on Wednesday, September 9th. They set a “buy” rating and a $250.00 target price for the company. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $235.23.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.